Ghp Investment Advisors, Inc. Amgen Inc Transaction History

Ghp Investment Advisors, Inc.

$2.05 Billion
Q1 2025

A detailed history of Ghp Investment Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Ghp Investment Advisors, Inc. holds 27,344 shares of AMGN stock, worth $7.88 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

27,344

Previous 26,486 3.24%

Holding current value

$7.88 Million

Previous $6.9 Million 23.41%

% of portfolio

0.41%

Previous 0.33%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 23, 2025	BUY	$258.59 - $327.36 $221,870 - $280,874	858 Added 3.24%	27,344 $8.52 Million
Q4 2024 Jan 27, 2025	BUY	$258.78 - $328.31 $406,802 - $516,103	1,572 Added 6.31%	26,486 $6.9 Million
Q3 2024 Oct 24, 2024	BUY	$309.38 - $337.38 $310,926 - $339,066	1,005 Added 4.2%	24,914 $8.03 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $454,557 - $552,406	1,730 Added 7.8%	23,909 $7.47 Million
Q1 2024 Apr 25, 2024	BUY	$268.87 - $324.56 $220,473 - $266,139	820 Added 3.84%	22,179 $6.31 Million
Q4 2023 Jan 26, 2024	BUY	$255.7 - $288.46 $181,802 - $205,095	711 Added 3.44%	21,359 $6.15 Million
Q3 2023 Oct 17, 2023	BUY	$218.65 - $271.46 $114,572 - $142,245	524 Added 2.6%	20,648 $5.55 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $370,258 - $437,823	1,728 Added 9.39%	20,124 $4.47 Million
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $214,500 - $261,440	950 Added 5.45%	18,396 $4.45 Million
Q4 2022 Feb 16, 2023	BUY	$229.03 - $291.01 $223,991 - $284,607	978 Added 5.94%	17,446 $4.58 Million
Q3 2022 Oct 28, 2022	BUY	$224.46 - $253.15 $173,507 - $195,684	773 Added 4.93%	16,468 $3.71 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $287,003 - $319,384	1,244 Added 8.61%	15,695 $3.82 Million
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $780,162 - $863,064	3,558 Added 32.66%	14,451 $3.49 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $209,022 - $239,207	-1,051 Reduced 8.8%	10,893 $2.45 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $175,971 - $206,172	829 Added 7.46%	11,944 $2.54 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $437,028 - $484,850	-1,871 Reduced 14.41%	11,115 $2.71 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $260,300 - $303,337	1,173 Added 9.93%	12,986 $3.23 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $360,921 - $429,793	1,668 Added 16.44%	11,813 $2.72 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $464,137 - $516,159	1,978 Added 24.22%	10,145 $2.58 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $100,091 - $122,826	-506 Reduced 5.83%	8,167 $1.93 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $75,629 - $100,305	-415 Reduced 4.57%	8,673 $1.76 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $6,433 - $8,268	34 Added 0.38%	9,088 $2.19 Million
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $253,330 - $303,542	-1,455 Reduced 13.85%	9,054 $1.75 Million
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $64,179 - $75,232	385 Added 3.8%	10,509 $1.94 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $11,756 - $13,252	65 Added 0.65%	10,124 $1.92 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $193,742 - $226,159	1,086 Added 12.1%	10,059 $1.96 Million
Q3 2018 Oct 17, 2018	BUY	$185.29 - $208.89 $5,188 - $5,848	28 Added 0.31%	8,973 $1.86 Million
Q2 2018 Aug 17, 2018	SELL	$166.05 - $186.51 $31,383 - $35,250	-189 Reduced 2.07%	8,945 $1.65 Million
Q1 2018 Apr 25, 2018	BUY	$169.43 - $198.0 $21,856 - $25,542	129 Added 1.43%	9,134 $1.56 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $64,477 - $72,041	382 Added 4.43%	9,005 $1.57 Million
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $1.44 Million - $1.65 Million	8,623	8,623 $1.61 Million

Others Institutions Holding AMGN

# of Institutions

3,309

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghp Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ghp Investment Advisors, Inc. with notifications on news.

Account

Ghp Investment Advisors, Inc. Amgen Inc Transaction History